Lavenius, E <br/><br/>
Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.  [electronic resource] 

 -  Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research  Jun 1995 
 - 727-36 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1044-9523 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Differentiation--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Neoplasm Proteins--biosynthesis<br/>Nerve Growth Factors--pharmacology<br/>Neuroblastoma--pathology<br/>Phosphorylation--drug effects<br/>Protein Processing, Post-Translational--drug effects<br/>Proto-Oncogene Mas<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins c-fos--biosynthesis<br/>Proto-Oncogenes<br/>Receptor Protein-Tyrosine Kinases--genetics<br/>Receptor, trkA<br/>Receptors, Nerve Growth Factor--genetics<br/>Recombinant Fusion Proteins--metabolism<br/>Transfection<br/>Tumor Cells, Cultured